同系小鼠原位同种异体移植物模拟胰腺癌

Overview

This protocol outlines the generation of syngeneic mouse orthotopic allografts of pancreatic ductal adenocarcinoma (PDAC), which mimic the disease's biology and therapeutic responses. These models are essential for preclinical studies due to their rapid and reproducible tumor progression.

Key Study Components

Area of Science

• Neuroscience
• Oncology
• Preclinical Research

Background

• PDAC is a challenging cancer with poor prognosis.
• Syngeneic models provide a relevant biological context for studying tumor behavior.
• These models allow for the assessment of drug responses in an immunocompetent environment.
• Reproducibility is crucial for validating experimental results.

Purpose of Study

• To establish a reliable method for creating PDAC models.
• To facilitate studies on tumor progression and treatment efficacy.
• To enhance understanding of PDAC biology in a syngeneic context.

Methods Used

• Washing PDAC cells with phosphate buffered saline (PBS).
• Detaching cells using trypsin for cell culture.
• Resuspending cells in DMEM with fetal bovine serum and antibiotics.
• Injecting the cell suspension into the pancreas of syngeneic mice.

Main Results

• Successful establishment of PDAC models in vivo.
• Demonstrated reproducibility of tumor growth.
• Ability to study drug responses in a relevant biological setting.
• Insights into the tumor microenvironment and its effects on progression.

Conclusions

• Syngeneic mouse models are valuable for PDAC research.
• This protocol provides a framework for future studies.
• Further research can lead to improved therapeutic strategies.

Frequently Asked Questions